Herpes simplex virus vectors and gene transfer to brain.
Experiments are in progress to engineer herpes simplex virus type 1 as a gene transfer vector for the nervous system. This virus is well suited for this purpose due to its ability to persist for long periods in a latent state in neurons wherein lytic genes are inactive and a unique viral promoter is capable of inducing transcription from the latent viral genome. The virus can be highly cytotoxic for neurons, however, and thus genes which initiate the lytic cycle must be deleted from the genome in order to force the virus into latency. Candidate genes include the immediately early functions ICP0, ICP27, ICP4 and the virus host shut-off function. The design of a suitable promoter regulator capable of expressing foreign genes during latency must also be developed. Many promoters including strong viral promoters and neuronal-specific cellular promoters have proved to be inadequate due to the transient nature of their activity from the viral vector genome and the viral latency promoter region appears to be weakly active in brain. Current efforts concern the development of auto-regulatable promoters which can remain active even if the viral genome is bound by chromatin.
Department of Molecular Genetics & Biochemistry, University of Pittsburgh School of Medicine, PA.
J C
JC
Glorioso
W F
WF
Goins
D J
DJ
Fink
N A
NA
DeLuca
D001483:Base Sequence; D001921:Brain / Q000821:virology*; D002843:Chromatin / Q000378:metabolism; D003588:Cytopathogenic Effect, Viral; D015967:Gene Expression Regulation, Viral; D018014:Gene Transfer Techniques; D005814:Genes, Viral; D005822:Genetic Vectors; D006801:Humans; D008845:Microinjections; D008969:Molecular Sequence Data; D009474:Neurons / Q000821:virology; D011401:Promoter Regions, Genetic; D011993:Recombinant Fusion Proteins / Q000096:biosynthesis; D011995:Recombination, Genetic; D018139:Simplexvirus / Q000235:genetics* / Q000502:physiology; D013238:Stereotaxic Techniques; D014158:Transcription, Genetic; D014614:Vaccines, Synthetic; D017735:Virus Latency
D002843:Chromatin; D011993:Recombinant Fusion Proteins; D014614:Vaccines, Synthetic